Hematopoietic cell growth, dierentiation, and commitment to a restricted lineage are guided by a set of cytokines acting exclusively on cells expressing the corresponding cytokine receptor. The macrophage colony stimulating factor (M-CSF, also termed CSF-1) and its cognate receptor, the tyrosine kinase c-Fms, are essential for monocyte and macrophage development. The underlying molecular mechanism, however, is poorly understood. Here we identi®ed a novel Fms-interacting protein (FMIP, MW 78 kDa) which binds transiently via its Nterminal 144 residues to the cytoplasmic domain of activated Fms-molecules. Binding of FMIP was paralleled by rapid tyrosine phosphorylation within the binding domain which drastically reduced its ability to associate with Fms. Binding was speci®c as evidenced by co-immunoprecipitation and association with recombinant GST-Fms fusion proteins. No binding was observed with the tyrosine phosphorylated cytoplasmic domains of c-Kit, TrkA, c-Met, and the insulin receptor. The role of FMIP in hematopoietic dierentiation was studied in the bipotential myeloid progenitor cell line, FDC-P1Mac11. Overexpression of FMIP prevented M-CSF induced macrophage dierentiation. Instead, cells dierentiated into granulocytes. Our data suggest that the level of FMIP expression could form a threshold that decides about dierentiation either into macrophages or into granulocytes.
Introduction
Although there is an increasing knowledge regarding the molecular mechanisms which are activated and responsible for survival and proliferation of hematopoietic cells, little is known of the signalling events leading to dierentiation into mature blood cells (Cross et al., 1997) . The macrophage colony stimulating factor (M-CSF, also termed CSF-1) and its receptor, c-Fms, trigger growth, dierentiation and survival of cells in the monocyte/macrophage lineage. The M-CSF receptor belongs to the family of receptor tyrosine kinases.
It is structurally most closely related to c-Kit (Ullrich and Schlessinger, 1990) , the receptor for the hematopoietic stem cell factor (SCF) which controls differentiation of stem cells, mast cells and granulocytes (Broudy, 1997) . Binding of the growth factors causes dimerization of the receptors and activation their inherent receptor tyrosine kinases leading to autophosphorylation of the cytoplasmic domains at multiple tyrosine residues. The newly formed phosphotyrosines constitute binding sites for Src homology 2 (SH2) domain-containing cytoplasmic proteins which are thought to participate in the control of mitogenic or dierentiation pathways, cell metabolism, and/or cell morphology.
The Fms tyrosine kinase was reported to interact with several SH2 domain-containing proteins, including the growth factor receptor bound protein 2 (Grb2; van der Geer and Hunter, 1993), STAT1 (Novak et al., 1996) , the p85 subunit of phosphatidyl-inositol-3'(PI-3') kinase (Reedijk et al., 1992) , the p120RasGTPase activating protein (GAP; Trouliaris et al., 1995) , phospholipase C-g (PLC-g; Bourette et al., 1997) , cSrc (Courtneidge et al., 1993) , SH2-containing inositol-5-phosphatase (SHIP; Lioubin et al., 1996) and p55, a polypeptide of yet unknown function (Joos et al., 1996) . Although each of these proteins binds to c-Fms in response to M-CSF stimulation, the pathway causing macrophage dierentiation remains elusive.
To understand the molecular principles underlying this dierentiation step, we employed a yeast twohybrid screening protocol based on the tyrosinephosphorylated C-terminal domain of mouse c-Fms as a bait. We identi®ed a novel Fms interacting protein, termed FMIP, which interacted with activated Fms-molecules, but failed to bind to c-Kit, c-Met, TrkA, or the insulin receptor. We show that M-CSF treatment of the mouse myeloid progenitor cell line, FDC-P1Mac11 cells (Gliniak and Rohrschneider, 1990) induces macrophage dierentiation. Overexpression of FMIP in these cells abrogates this M-CSF-speci®c signal, but induced dierentiation into granulocytes. Our data suggest that the endogenous level of FMIP constitutes a threshold that decides about dierentiation either into macrophages or into granulocytes.
Results

Detection of FMIP, a novel binding partner of c-Fms
To identify proteins which speci®cally interact with the cytoplasmic domain of the M-CSF receptor, we employed yeast two-hybrid screening (Field and Song, 1989; Vojtek et al., 1993) . The bait consisted of the cytoplasmic domain of mouse c-Fms fused to the C terminus of the DNA-binding and dimerization domain of LexA. Upon expression of the fusion protein in yeast cells, dimerization leads to interchain tyrosine phosphorylation of the two Fms receptor segments (Mancini et al., 1997) , thus allowing us to screen a mouse embryo cDNA library with a Fms molecule representing the activated receptor phenotype. A total of 157 cDNA clones of various length were obtained, together encoding seven dierent proteins. Six of these proteins were previously identi®ed SH2 domain containing proteins such as PI-3' kinase, Grb2, PLC-g, and c-Src. We also observed interactions between c-Fms and Grb10 and c-Abl, respectively. These two proteins have not previously been shown to associate with Fms and, therefore, the signi®cance of our ®nding remains to be established. In addition, we detected the interaction with a novel Fmsinteractive protein, FMIP (MW 78 kDa; 683 residues, four independent clones indicated in Figure 1a ). FMIP is not related to any protein of known function and the deduced amino acid sequence fails to provide insights regarding its biological role. In the course of cloning of chromosome 22, the corresponding human protein was postulated from the presence of an open reading frame as an anonymous protein, pk1.3, of unknown function (Xie et al., 1993) . Mouse and human FMIP share 89.6 and 95.6% identity at the nucleotide and amino acid levels, respectively (Figure 1b ). This highly conserved protein lacks classical SH2 and PTB domains and it remains to be established whether the classical WWdomain binding site is indeed engaged in protein/ protein interactions (Figure 1) . A short polar region composed of ten negatively charged and three serine residues shows the typical features of a casein kinase II phosphorylation site. This segment also contains a typical PEST domain, i.e. a target sequence for proteolytic degradation. Clusters of basic amino acid residues could act as nuclear localization signals, although expression of full-length FMIP in various mammalian cells indicated a cytoplasmic distribution. Finally, the signi®cance of the leucine zipper containing four heptad repeats (Figure 1a ,b) remains to be established.
Ubiquitous expression of FMIP
We next analysed the tissue speci®city of FMIP expression. Mouse multiple tissue Northern ®lters were screened for the presence of FMIP-speci®c mRNA. As demonstrated in Figure 2a , speci®c transcripts of 2.7 kb were detected in all tissues with highest levels in testis, liver and heart and lower levels in the kidney and spleen. Further analyses revealed various levels of transcription of the FMIP gene in six established cell lines including the IL-3 dependent bipotential myeloid progenitor cell line FDC-P1Mac11. In comparison to MDCK or M-07e cells, FDCP1Mac11 cells expressed the FMIP gene about tenfold less (Figure 2b ). Furthermore, elevated levels of FMIP transcripts are present in human foetal kidney and liver ( Figure 2b ). This latter organ functions as a hematopoietic maturation and dierentiation site.
FMIP forms a complex with Fms molecules in FDC-P1Mac11 cells
To demonstrate the protein/protein interaction between FMIP and Fms in vivo, we over-expressed the FMIP gene in FDC-P1Mac11 cells and isolated 17 dierent clones, each constitutively expressing distinct levels of a myc-tagged FMIP. FDC-P1Mac11 cells are known to express functional M-CSF receptors and to dierentiate into macrophages upon withdrawal of IL-3 and stimulation with M-CSF (Gliniak and Rohrschneider, 1990) . The 17 clones showed an unaltered cell morphology and IL-3-dependency of growth. To study the eects of M-CSF on the FMIP-Fms association, we ®rst starved the cells for 5 h in medium lacking IL-3 or serum factors. Following stimulation with M-CSF for various length of time, cells were lysed for immunoprecipitations using a Fms-speci®c antiserum. Precipitated material was analysed for the presence of FMIP by SDS ± PAGE and Western-blotting using myc, Fms-, or phosphotyrosine (4G10)-speci®c antibodies (Figure 3) . Following M-CSF stimulation, tyrosine phosphorylation of Fms was observed throughout the experiment. Prior to M-CSF stimulation (0 min), no FMIP was detectable in the Fms-speci®c immune complexes. In contrast, 3 min and, though to a lesser extent, 5 min after M-CSF stimulation, FMIP clearly co-precipitated with Fms, whilst it was again not detectable 10 min The N-terminal 144 amino acid residues of FMIP are involved in binding to activated Fms
To further support this ®nding, we again employed the yeast two-hybrid system, including a kinase-negative Fms mutant in which the ATP binding site, K613, was replaced by a methionine residue. At the same time, we wanted to use this approach to (i) map the minimal essential domain of FMIP required for binding and to (ii) correlate binding of FMIP with the presence of particular phosphotyrosine residues of Fms.
A comparison of the Fms binding properties of wt-FMIP, the four FMIP polypeptides identi®ed in the course of the yeast two-hybrid screening and additional C-terminal deletion mutants, indicated that optimal binding was retained with an N-terminal fragment encompassing the ®rst 144 residues (Figure 4a ). The Cterminal deletion of a further ten residues, yielding FMIP(1 ± 134), abolished binding. FMIP(11 ± 144) displayed about 40% of the binding activity of FMIP(1 ± 144), and the deletion of additional ten Nterminal residues virtually abolished binding ( Figure  4a ).
To study whether the FMIP/Fms interaction relied on the presence of particular phosphotyrosine residues of Fms, we employed a set of Fms mutants in which established binding sites for de®ned binding partners were destroyed (Figure 4b ). These mutants included Y543F devoid of the p55 binding site (Joos et al., 1996) , Y558/568F in which the reported Src attachment sites were mutated (Courtneidge et al., 1993) , Y705F lacking the binding site for Stat1 (Novak et al., 1996) , Y720F with a mutation of the PI-3'-kinase binding site (Reedijk et al., 1992, Y807F lacking the putative binding site of p120RasGAP (Trouliaris et al., 1995) , and Y696/921F in which the two Grb2 binding sites are destroyed (Mancini et al., 1997) . However, with the exception of the Y807F mutant, none of the aforementioned mutations in¯uenced binding of FMIP to a signi®cant extent (Figure 4b ). The reduced binding capacity of this latter mutant is likely, however, to be caused by a diminished tyrosine kinase activity in yeast cells which was observed exclusively with this mutant. In keeping with this notion, PI-3' kinase and Grb2 also showed about 50% reduced binding to this mutant (Mancini et al, 1997) . Since it is unclear which of the remaining ten tyrosine residues of the cytoplasmic domain of Fms become also phosphorylated, additional extensive experiments will be required to solve the issue whether the interaction between FMIP and Fms depends on one or more phosphotyrosine residues. It should be noted, however, that the kinase-negative Fms mutant, K613M, showed absolutely no interaction with FMIP (Figure 4b ), again + RNA from mouse NIH3T3, FDC-P1Mac11, P-815, PC12, MDCK, and M-07e cells, and the same for a human foetal multiple tissue Northern blot (Clontech) . Note that foetal liver is the organ in which maturation and dierentiation of blood cells takes place Figure 3 FMIP association with c-Fms requires M-CSF stimulation. FDC-P1Mac11 cells transfected with myc-tagged FMIP were maintained for 5 h in medium lacking FCS and IL-3 (7), prior to stimulation with M-CSF for 3, 5 and 10 min. Cell lysates obtained from 5610 6 cells were subjected to immunoprecipitation using an anti mouse c-Fms antibody. Immunoprecipitates were analysed by SDS ± PAGE and immunoblotting using the anti-myc, anti-Fms and anti-phosphotyrosine (pY) antibodies. The presence of equal amounts of FMIP was demonstrated by Western blotting of cell lysates using the anti-myc antibody supporting the idea that FMIP binds exclusively to activated Fms molecules.
FMIP does not bind to other activated receptor tyrosine kinases
To further analyse the speci®city of the FMIP/Fms interaction, similar binding analyses were performed with four additional activated receptor tyrosine kinases including c-Kit, TrkA, c-Met, and the insulin receptor. Western blotting with anti-phosphotyrosine clearly demonstrated that these receptor moieties were phosphorylated on tyrosine in the yeast two-hybrid assay. Furthermore, control experiments revealed the expected binding pro®le towards PI-3' kinase and PLCg (Figure 5b ). In agreement with a previous report (Yokouchi et al., 1997) , wt-c-Kit was not fully active in yeast cells and associated with PI-3' kinase only (data not shown), whereas the activated form, D816V-c-Kit, bound to both PI-3' kinase and PLCg ( Figure 5 ). Neither of these two c-Kit variants, nor any of the other aforementioned activated receptor tyrosine kinases, bound to murine or human FMIP, thus underscoring the speci®city of FMIP for activated Fms (Figure 5a ).
FMIP is a substrate of the Fms-associated tyrosine kinase and phosphorylation of FMIP down-regulates its binding to Fms
We next wanted to see whether the transient contact between FMIP and the M-CSF-activated Fms tyrosine kinase was paralleled by a phosphorylation of FMIP. We analysed FMIP-containing immune complexes from M-CSF stimulated and nonstimulated FMIPtransfectants by Western blotting using anti-myc or anti-phosphotyrosine antibodies ( Figure 6 ). As expected, no tyrosine phosphorylation of FMIP was observed after the 5 h starvation period. In contrast, lysates generated 3, 5 or 10 min after stimulation (Yokouchi et al., 1997) , TrkA, c-Met or the insulin receptor (IR) were co-transformed with pVP16 carrying the cDNA of mouse FMIP(1 ± 154) (mFMIP), human FMIP(1 ± 154) (hFMIP), or the SH2 domains of PI-3' kinase or PLC-g. 10 000 cells of four independent transformants were analysed for uorescence intensity using a Becton Dickinson FACScan¯ow cytometer clearly contained FMIP that was phosphorylated on tyrosine ( Figure 6a) . In control experiments, we stimulated the same FMIP transfectants with GM-CSF. It is well established that FDC-P1Mac11 cells express functional GM-CSF receptors and that GM-CSF treatment leads to an activation of the JAK2 tyrosine kinase paralleled by a dierentiation into granulocytes (Quelle et al., 1994; Gliniak and Rohrschneider, 1990) . However, the activation of the GM-CSF-speci®c signalling cascades did not cause FMIP phosphorylation (Figure 6b) .
The entire FMIP molecule contains 28 tyrosine residues each of which could potentially become phosphorylated (Figure 6c ). To map the tyrosine phosphorylation sites, we generated four GST-fusion proteins containing various portions of FMIP and used them as substrates in in vitro Fms-speci®c tyrosine kinase reactions. Only GST-FMIP(1 ± 154), harbouring the Fms binding domain, became phosphorylated. This GST-fusion protein contains seven tyrosine residues, two of which, Y(126) and Y(135), are also present in GST-FMIP(87 ± 280), which was not phosphorylated. It is likely, therefore, that one (or several) of the ®ve tyrosines clustered between Y36 and Y59 are the targets for the Fms tyrosine kinase in vitro. With respect to the in vivo scenario, however, we cannot rule out the possibility that other tyrosine kinases such as Src or Tyk2 are engaged in the phosphorylation of FMIP.
To test whether the short-lived tyrosine phosphorylation of the Fms binding domain of FMIP modulated the Fms/FMIP interaction, we compared the Fms binding properties of tyrosine-phosphorylated GST-FMIP(1 ± 154) to those of its nonphosphorylated isoform. The tyrosine-phosphorylated isoform was isolated from E. coli strain TKX which expresses an active Elk tyrosine kinase (Joos et al., 1996) . Western blot analyses with anti-phosphotyrosine proved that this protein was indeed phosphorylated on tyrosine (Figure 7) . The ligand, 32 P-labelled autophosphorylated Fms was generated by an in vitro kinase reaction of Fms-speci®c immune complexes and liberated from these complexes by a low pH-shock treatment. Such activated Fms molecules bound to nonphosphorylated GST-FMIP(1 ± 154) about 20-fold stronger than to the tyrosine-phosphorylated GST-fusion protein ( Figure  7) . No binding of Fms was observed with GST alone. As we have no way of determining the ecacy of tyrosine phosphorylation in E. coli strain TKX, it is well possible that the residual binding observed with the tyrosine-phosphorylated GST-FMIP species has actually to be ascribed to nonphosphorylated material. Taking into account all the pieces of information regarding the FMIP/Fms interaction, we may conclude that FMIP interacts and binds to the activated Fms tyrosine kinase only transiently: binding results in a rapid phosphorylation of FMIP within the Fmsbinding domain itself which in turn causes a dissociation of the two molecules.
Overexpression of FMIP causes M-CSF mediated dierentiation into granulocytes
To obtain insights into the biological function of FMIP, we studied the dierentiation pattern of the FMIP-expressing FDC-P1Mac11 cells. Two clones (Figure 8c ). In contrast, the same treatment led to a signi®cant increase in the doubling rate of the two FDCP1Mac11 transfectants (Figure 8b ). These FMIP overexpressing cell lines continued to grow as suspension cultures. About 10% of them developed lobulated or bean-shaped nuclei of reduced size in proportion to the cytoplasm. After 4 days, the characteristic ring-nucleated structures of granulocytes appeared (Figure 8c ). These phenotypic changes indicate an unexpected M-CSF induced dierentiation into granulocytes. Interestingly, additional FDC-P1Mac11 transfectants expressing lower levels of FMIP grew more slowly in the presence of M-CSF and fewer cells changed to the granulocytespeci®c phenotype (data not shown). Apparently, the endogenous concentration of FMIP plays a pivotal role in the decision of whether the bipotential progenitor cells dierentiate into macrophages or granulocytes.
Discussion
Employing a yeast two-hybrid screening, we detected FMIP, a novel Fms interactive protein and substrate for the Fms tyrosine kinase. Here we studied the molecular basis for FMIP/Fms interaction and investigated the role of FMIP in M-CSF induced hematopoietic dierentiation of the bipotential myeloid progenitor cell line, FDC-P1Mac11. Six major observations were made which support the notion that the interaction between FMIP and Fms is indeed highly speci®c, and which suggest that this interaction participates in the control of cell dierentiation: (1) Binding of FMIP to Fms was mediated via its Nterminal domain encompassing 144 amino acid residues; (2) Binding required M-CSF-activated Fms receptor molecules. No binding was obtained with the activated cytoplasmic domains of TrkA, c-Met, the Figure 7 Tyrosine phosphorylation of FMIP impairs its interaction with the M-CSF receptor. GST-FMIP(1 ± 154), encompassing the Fms binding domain or GST alone, were produced in bacterial strains Trx or TKX to generate either nonphosphorylated or phosphorylated FMIP-species, respectively. GST-fusion protein or GST (5 mg each) were bound to GTagarose beads and incubated with 32 P-labelled v-Fms, as obtained by an in vitro kinase reaction. Following washing, bound protein was analysed by SDS ± PAGE. To demonstrate tyrosine phosphorylation of FMIP(1 ± 154) from strain TKX, aliquots of the same samples were analysed by immunoblotting using an antiphosphotyrosine antibody. As a control, aliquots were analysed by SDS ± PAGE and staining with Coomassie brilliant blue insulin receptor, and c-Kit. c-Kit and c-Fms are remarkably related regarding the distribution and structure of binding sites for SH2 domain containing proteins (Songyang et al., 1993) What are the molecular mechanism(s) by which FMIP exerts its regulatory function? The protein contains several sequences which typically serve as binding sites for proteins with WW-, PTB-, and SH2-domains (Pawson and Scott, 1997) . It is likely, therefore that FMIP interacts with additional cellular proteins which we are currently trying to identify. Furthermore, the presence of a PEST domain could indicate that FMIP ± perhaps following phosphorylation ± is a target for proteolytic degradation. If so, the C-terminal product of FMIP which still contains a putative nuclear localization sequence and the leucine zipper could serve an as yet unknown function in the nucleus. In this context it is important to note that a deletion of the 88 N-terminal residues results in a nuclear accumulation of the truncated FMIP-fragment (T Tamura, unpublished data).
A most puzzling observation of our studies regards the M-CSF-induced dierentiation of FMIP-overexpressing FDC-P1Mac11 cells into granulocytes. Normally, the M-CSF speci®c signalling would trigger dierentiation of these cells which, as we show here do express only low endogenous levels of FMIP, into macrophages. Although we have no information regarding the role of FMIP in additional cell lines or tissues, and although we did not test the FDCP1Mac11 transfectants under conditions that would lead to granulocyte dierentiation, it is intriguing to speculate that the concentration of cytoplasmic FMIP could play the pivotal role in the decision of whether to dierentiate into macrophages or granulocytes. In wt-FDC-P1Mac11 cells, endogenous levels of FMIP could be eciently processed by M-CSF/Fms-mediated tyrosine phosphorylation, perhaps subsequent proteolytic degradation, and nuclear translocation. In keeping with this idea is the observation that the concentration of phosphorylated FMIP declined 10 min after M-CSF-stimulation (Figure 6a ). This processing pathway would result in macrophage dierentiation. In contrast, overexpression of FMIP could saturate Fms, resulting in a predominance of cytoplasmic FMIP which would favour granulocyte dierentiation. In accordance with the idea that the concentration of cytoplasmic FMIP sets a threshold is the ®nding that FDC-P1Mac11 transfectants which expressed about 50% less FMIP in comparison to clones #2 and #12, displayed reduced growth rates in the presence of M-CSF and showed a diminished ability to change into granulocytes.
Clearly, additional experiments are required to support this potential signalling pathway. Future experiments will also address the search for additional FMIP binding partners that act downstream of FMIP phosphorylation. Preliminary data indicate that FMIP can form complexes with protein kinase Ca (PKCa; Tamura et al., manuscript in preparation). The central role of this kinase for macrophage dierentiation is well documented. Whetton et al. (1994) reported that M-CSF stimulation of primary bone marrow cultures resulted in a nuclear translocation of PKCa and macrophage dierentiation. Conversely, application of inhibitors of PKCa and simultaneous stimulation of these cells led to granulocyte dierentiation (Pierce et al., 1998) . Since activators of PKCa can overrule the eects of FMIP also in FDC-P1Mac11 transfectants, we are convinced that the M-CSF/Fms and the PKCaspeci®c signalling cascades are interlinked.
Materials and methods
Plasmid constructions, transfection, and yeast two-hybrid screening
The construction of LexA fusion genes encoding the cytoplasmic domains of c-Fms, TrkA, c-Met, and c-Kit downstream of LexA, the expression in E. coli pBTM116 and S. cerevisiae strain L40 were described previously (Weidner et al., 1996; Mancini et al., 1997) . Fms-mutants containing tyrosine/phenylalanine replacements have been described (Mancini et al., 1997) . Yeast clones were selected in medium lacking uracil and tryptophan. A single colony, selected for expression of the LexA-fusion protein, was tested for autophosphorylation and used for transformation with the VP16 cDNA library derived from a 10 ± 11 day mouse embryo (Vojtek et al., 1993; Weidner et al., 1996; Mancini et al., 1997) . GST-FMIP fusion proteins were generated in the pGex system (Pharmacia, Freiburg, Germany). To generate myc-tagged FMIP, the EcoRI ± DraI (1 ± 2047) fragment of hFMIP cDNA (Xie et al., 1993) was cloned into pcDNA3.1/ Myc-His (Invitrogen, Carlsbad, USA) to yield pFMIP/MycHis.
Binding assay using the two-hybrid system
The qualitative and quanti®cation evaluations of various twohybrid protein/protein interaction was described previously (Mancini et al., 1997) .
Northern blotting
Northern blotting with a FMIP-speci®c and actin-speci®c probes were performed as described . Mouse multiple tissue northern ®lters (MTN 2 ) were purchased from Clontech Lab. Inc (Palo Alto, USA).
Cells and antibodies
NRK cells expressing the v-fms gene were grown in Dulbecco modi®ed Eagle's medium supplemented with 10% FCS. FDC-P1Mac11 cells were maintained in the same medium, however, supplemented with WEHI3BD-conditioned medium as a source of IL-3 employing a concentration that stimulated optimal cell growth. M-CSF (Sigma, MuÈ nchen, Germany) was added at concentration of 2000 U/ml. Rat sera against vFms and mouse-c-Fms were used as described previously (Tamura et al., 1986; Just et al., 1993) . Monoclonal antibodies against phosphotyrosine (4G10), against Mycepitope (9E10), anti c-Fms rabbit IgG were from Upstate Role of FMIP in macrophage and granulocyte differentiation T Tamura et al Biotechnology Incorporated (Lake Placid, NY, USA) or from Santa Cruz Biotechnology (Santa Cruz, USA), respectively.
Tyrosine kinase assays, immunoprecipitation, immunoblotting
These assays were performed as published (Joos et al., 1996; Mancini et al., 1997) .
Binding of cellular proteins to GST-FMIP fusion proteins
Strain TKX-1 (TKX, Stratagene, La Jolla, USA) was used for the isolation of phosphorylated GST-FMIP fusion proteins. Phosphorylated GST-fusion proteins were produced as recommended by the manufacturer. The corresponding nonphosphorylated molecular species were isolated from E. coli strain BL21(DE3)-pT-Trx (Trx) (Yasukawa et al., 1995) . Puri®ed GST-fusion proteins were bound for 1 h at 48C to glutathione (GT) agarose beads (40 ml slurry; Pharmacia) suspended in FMIP/Fms binding buer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.01% Tween20, 1% Trasylol, 20 mg/ml BSA and 200 mM sodium orthovanadate). Precharged beads were incubated overnight at 48C with 32 P-labelled Fms, as generated by in vitro autophosphorylation or obtained from FDC-P1Mac11 cell lysates in a total volume of 2 ml of binding buer. Beads were washed ®ve times with binding buer and pellets were analysed by SDS ± PAGE.
Generation of FMIP overexpressing FDC-P1Mac11 cells
Transfections of FDC-P1Mac11 cells with pFMIP/Myc-His DNA were performed with the Superfect 2 reagent (Qiagen, Hilden, Germany). Seventeen dierent neomycin-resistant cell clones were obtained by growth in G418-containing selection medium and limiting dilution. Individual clones showed identical IL-3 dependancy of growth and cell morphology like wild-type cells. In this study two clones, FDC-P1-FMIP#2 and FDC-P1-FMIP#12, were used for further experiments.
